![]() |
Volumn 124, Issue 1, 2011, Pages
|
Letter by Alter and Rupp regarding article, "oMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction"
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
G PROTEIN COUPLED RECEPTOR 120;
OMEGA 3 FATTY ACID;
CARDIAC PATIENT;
CARDIOVASCULAR RISK;
CLINICAL STUDY;
DRUG HALF LIFE;
ECHOCARDIOGRAPHY;
HEART INFARCTION;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART RATE VARIABILITY;
HUMAN;
LETTER;
NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SUDDEN DEATH;
WALL STRESS;
DEATH, SUDDEN, CARDIAC;
DIET;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDPOINT DETERMINATION;
EVIDENCE-BASED MEDICINE;
FATTY ACIDS, OMEGA-3;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MYOCARDIAL INFARCTION;
MYOCARDIAL REVASCULARIZATION;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SECONDARY PREVENTION;
STROKE VOLUME;
TIME FACTORS;
TREATMENT OUTCOME;
VENTRICULAR REMODELING;
|
EID: 79960352487
PISSN: 00097322
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.110.013607 Document Type: Letter |
Times cited : (6)
|
References (5)
|